Quest Diagnostics reported stable revenue but mixed profit metrics for Q2 2024. Revenue for the second quarter totaled $2.4 ...

Quest Diagnostics Inc. DGX benefits from its robust utilization of the Advanced Diagnostics portfolio offerings. The company also expands through strategic acquisitions, completing eight transactions ...

GRAIL's Galleri Test Now Directly Available to Physicians in the U.S. Through Collaboration With Quest Diagnostics, Delivering a More Streamlined Provider and Patient Experience MENLO PARK ...

Quest Diagnostics’ growth in the Physician Lab Services is backed by new customer ... their increasing adoption is driving a favorable test mix and growth in test per requisition for the company.

In an age of capitation and value-based care, health plans must work harder than ever to offer tailored support to higher-risk members with chronic conditions.